The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is a transmembrane protein that is a receptor for members of the epidermal growth factor family (EGF family) of extracellular protein ligands.
This report aims to provide a comprehensive presentation of the global market for Epidermal Growth Factor Receptor (EGFR) Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epidermal Growth Factor Receptor (EGFR) Inhibitor. This report contains market size and forecasts of Epidermal Growth Factor Receptor (EGFR) Inhibitor in global, including the following market information:
Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Epidermal Growth Factor Receptor (EGFR) Inhibitor market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The high efficacy of EGFR inhibitors in the treatment of various types of cancer indications has encouraged researchers to study its use in the treatment of inflammatory and monogenic diseases. Recent in-vitro research studies have suggested that EGFR mutations may cause indications such as eczema, psoriasis, and atherosclerosis. Although these studies are in the early stages of clinical trials, the huge unmet need and further advancements in research are expected to brighten the growth prospects of EGFR inhibitors market vendors in new research areas.
We surveyed the Epidermal Growth Factor Receptor (EGFR) Inhibitor companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Segment Percentages, by Type, 2022 (%)
Lung Cancer
Colorectal Cancer
Breast Cancer
Others
Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Segment Percentages, by Application, 2022 (%)
Hospital
Research Institutes and Research Institutions
Clinic
Other
Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Epidermal Growth Factor Receptor (EGFR) Inhibitor revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Epidermal Growth Factor Receptor (EGFR) Inhibitor revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen Inc.
AstraZeneca Plc
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
Novartis AG
Outline of Major Chapters:
Chapter 1: Introduces the definition of Epidermal Growth Factor Receptor (EGFR) Inhibitor, market overview.
Chapter 2: Global Epidermal Growth Factor Receptor (EGFR) Inhibitor market size in revenue.
Chapter 3: Detailed analysis of Epidermal Growth Factor Receptor (EGFR) Inhibitor company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Epidermal Growth Factor Receptor (EGFR) Inhibitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Overall Market Size
2.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size: 2022 VS 2030
2.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Players in Global Market
3.2 Top Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Companies Ranked by Revenue
3.3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Companies
3.4 Top 3 and Top 5 Epidermal Growth Factor Receptor (EGFR) Inhibitor Companies in Global Market, by Revenue in 2022
3.5 Global Companies Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Type
3.6 Tier 1, Tier 2 and Tier 3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Players in Global Market
3.6.1 List of Global Tier 1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Companies
3.6.2 List of Global Tier 2 and Tier 3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Markets, 2022 & 2030
4.1.2 Lung Cancer
4.1.3 Colorectal Cancer
4.1.4 Breast Cancer
4.1.5 Others
4.2 By Type - Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue & Forecasts
4.2.1 By Type - Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, 2018-2023
4.2.2 By Type - Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, 2024-2030
4.2.3 By Type - Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Research Institutes and Research Institutions
5.1.4 Clinic
5.1.5 Other
5.2 By Application - Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue & Forecasts
5.2.1 By Application - Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, 2018-2023
5.2.2 By Application - Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, 2024-2030
5.2.3 By Application - Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, 2022 & 2030
6.2 By Region - Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue & Forecasts
6.2.1 By Region - Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, 2018-2023
6.2.2 By Region - Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, 2024-2030
6.2.3 By Region - Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, 2018-2030
6.3.2 US Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, 2018-2030
6.3.3 Canada Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, 2018-2030
6.3.4 Mexico Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, 2018-2030
6.4.2 Germany Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, 2018-2030
6.4.3 France Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, 2018-2030
6.4.4 U.K. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, 2018-2030
6.4.5 Italy Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, 2018-2030
6.4.6 Russia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, 2018-2030
6.4.7 Nordic Countries Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, 2018-2030
6.4.8 Benelux Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, 2018-2030
6.5.2 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, 2018-2030
6.5.3 Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, 2018-2030
6.5.4 South Korea Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, 2018-2030
6.5.5 Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, 2018-2030
6.5.6 India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, 2018-2030
6.6.2 Brazil Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, 2018-2030
6.6.3 Argentina Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, 2018-2030
6.7.2 Turkey Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, 2018-2030
6.7.3 Israel Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, 2018-2030
6.7.4 Saudi Arabia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, 2018-2030
6.7.5 UAE Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, 2018-2030
7 Epidermal Growth Factor Receptor (EGFR) Inhibitor Companies Profiles
7.1 Amgen Inc.
7.1.1 Amgen Inc. Company Summary
7.1.2 Amgen Inc. Business Overview
7.1.3 Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Major Product Offerings
7.1.4 Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue in Global Market (2018-2023)
7.1.5 Amgen Inc. Key News & Latest Developments
7.2 AstraZeneca Plc
7.2.1 AstraZeneca Plc Company Summary
7.2.2 AstraZeneca Plc Business Overview
7.2.3 AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Major Product Offerings
7.2.4 AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue in Global Market (2018-2023)
7.2.5 AstraZeneca Plc Key News & Latest Developments
7.3 Eli Lilly and Co.
7.3.1 Eli Lilly and Co. Company Summary
7.3.2 Eli Lilly and Co. Business Overview
7.3.3 Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Major Product Offerings
7.3.4 Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue in Global Market (2018-2023)
7.3.5 Eli Lilly and Co. Key News & Latest Developments
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 F. Hoffmann-La Roche Ltd. Company Summary
7.4.2 F. Hoffmann-La Roche Ltd. Business Overview
7.4.3 F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Major Product Offerings
7.4.4 F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue in Global Market (2018-2023)
7.4.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.5 Novartis AG
7.5.1 Novartis AG Company Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Major Product Offerings
7.5.4 Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue in Global Market (2018-2023)
7.5.5 Novartis AG Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Opportunities & Trends in Global Market
Table 2. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Drivers in Global Market
Table 3. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Restraints in Global Market
Table 4. Key Players of Epidermal Growth Factor Receptor (EGFR) Inhibitor in Global Market
Table 5. Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Share by Companies, 2018-2023
Table 8. Global Companies Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Type
Table 9. List of Global Tier 1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2024-2030
Table 30. Amgen Inc. Company Summary
Table 31. Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Offerings
Table 32. Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (US$, Mn) & (2018-2023)
Table 33. Amgen Inc. Key News & Latest Developments
Table 34. AstraZeneca Plc Company Summary
Table 35. AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Offerings
Table 36. AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (US$, Mn) & (2018-2023)
Table 37. AstraZeneca Plc Key News & Latest Developments
Table 38. Eli Lilly and Co. Company Summary
Table 39. Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Offerings
Table 40. Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (US$, Mn) & (2018-2023)
Table 41. Eli Lilly and Co. Key News & Latest Developments
Table 42. F. Hoffmann-La Roche Ltd. Company Summary
Table 43. F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Offerings
Table 44. F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (US$, Mn) & (2018-2023)
Table 45. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 46. Novartis AG Company Summary
Table 47. Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Offerings
Table 48. Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (US$, Mn) & (2018-2023)
Table 49. Novartis AG Key News & Latest Developments
List of Figures
Figure 1. Epidermal Growth Factor Receptor (EGFR) Inhibitor Segment by Type in 2022
Figure 2. Epidermal Growth Factor Receptor (EGFR) Inhibitor Segment by Application in 2022
Figure 3. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue in 2022
Figure 8. By Type - Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share, 2018-2030
Figure 9. By Application - Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share, 2018-2030
Figure 10. By Type - Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share, 2018-2030
Figure 12. By Application - Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share, 2018-2030
Figure 14. By Region - Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share, 2018-2030
Figure 15. By Country - North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share, 2018-2030
Figure 16. US Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share, 2018-2030
Figure 20. Germany Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2030
Figure 21. France Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share, 2018-2030
Figure 28. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2030
Figure 32. India Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share, 2018-2030
Figure 34. Brazil Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share, 2018-2030
Figure 37. Turkey Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, (US$, Mn), 2018-2030
Figure 41. Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
